Power Law company profile

Radius Health

Biotech & Life Sciences · Cambridge, United States · Founded 2003 · IPO 2014 Thoroughbred

Global biopharmaceutical company focused on addressing unmet medical needs in the area of bone health

Valuation

$1.42B

Market cap · 2026

Revenue

$2.74B

Latest reported FY

EBITDA

$26M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

13 investors on Radius Health's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 13 investors entered at this stage

Biotech Growth

Saints Capital

Nordic Bioscience

Scottish Widows Investment Partnership

HealthCare Ventures

Brookside Capital

MPM Bio IV NVS Strategic Fund

Oxford Bioscience Partners

Wellcome Trust

Ipsen Pharma SA

MPM BioImpact

Scottish Widows

BB Biotech Ventures

Global footprint

Where Radius Health has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States99.3%

🇨🇦 Canada0.5%

🇮🇳 India0.5%

3 countries shown

Web traffic by country

6K monthly visits
across markets

🇺🇸 United States88.3%

🇮🇳 India11.7%

Top 2 markets shown

Market sentiment

What the market is saying about Radius Health

An AI-synthesized read of the highest-engagement posts about Radius Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Radius Health on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles